Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Point-of-Care Infectious Disease Diagnostics or Testing industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
Also Read: http://www.marketwatch.com/story/june-2021-report-on--global-point-...
The Point-of-Care Infectious Disease Diagnostics or Testing market can be split based on product types, major applications, and important countries as follows:
Key players in the global Point-of-Care Infectious Disease Diagnostics or Testing market covered in Chapter 12:
OJ-Bio Ltd.
Bio-Rad Labs Inc.
Trinity Biotech
Thermo Fisher Scientific Inc
Ortho-Clinical Diagnostic
Cardinal Health
Alere
BD & Company
Chembio Diagnostics Inc
Quest Diagnostics, Inc
Gene POC
F. Hoffmann-La Roche Ltd
Siemens Healthineers
bioMérieux SA
Sight Diagnostics Ltd.
Trivitron Healthcare
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-pv-phot...
In Chapter 4 and 14.1, on the basis of types, the Point-of-Care Infectious Disease Diagnostics or Testing market from 2015 to 2025 is primarily split into:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Other infectious disease POC
In Chapter 5 and 14.2, on the basis of applications, the Point-of-Care Infectious Disease Diagnostics or Testing market from 2015 to 2025 covers:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-pyelone...

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-surgery...
TABLE OF CONTENT :
Table of Content
1 Point-of-Care Infectious Disease Diagnostics or Testing Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Point-of-Care Infectious Disease Diagnostics or Testing
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Point-of-Care Infectious Disease Diagnostics or Testing industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Size, 2015 – 2020
2.1.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Size by Type, 2015 – 2020
2.1.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Size by Application, 2015 – 2020
2.1.4 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Point-of-Care Infectious Disease Diagnostics or Testing Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Point-of-Care Infectious Disease Diagnostics or Testing Analysis
3.2 Major Players of Point-of-Care Infectious Disease Diagnostics or Testing
3.3 Point-of-Care Infectious Disease Diagnostics or Testing Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Point-of-Care Infectious Disease Diagnostics or Testing
3.3.3 Labor Cost of Point-of-Care Infectious Disease Diagnostics or Testing
3.4 Market Distributors of Point-of-Care Infectious Disease Diagnostics or Testing
3.5 Major Downstream Buyers of Point-of-Care Infectious Disease Diagnostics or Testing Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Point-of-Care Infectious Disease Diagnostics or Testing Market, by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Market Share by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Production and Market Share by Type (2015-2020)
4.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate by Type (2015-2020)
4.3.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of HIV POC
4.3.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of Clostridium difficile POC
4.3.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of HBV POC
4.3.4 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of Pneumonia or Streptococcus associated infections
4.3.5 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of Respiratory syncytial virus (RSV) POC
4.3.6 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of HPV POC
4.3.7 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of Influenza/Flu POC
4.3.8 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of HCV POC
4.3.9 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of MRSA POC
4.3.10 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of TB and drug-resistant TB POC
4.3.11 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of HSV (Herpes Simplex Virus) POC
4.3.12 Global Point-of-Care Infectious Disease Diagnostics or Testing Value and Growth Rate of Other infectious disease POC
4.4 Global Point-of-Care Infectious Disease Diagnostics or Testing Price Analysis by Type (2015-2020)
5 Point-of-Care Infectious Disease Diagnostics or Testing Market, by Application
5.1 Downstream Market Overview
5.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Market Share by Application (2015-2020)
5.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate of Hospitals (2015-2020)
5.3.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate of Clinics (2015-2020)
5.3.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate of Home (2015-2020)
5.3.4 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate of Assisted Living Healthcare Facilities (2015-2020)
5.3.5 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate of Laboratories (2015-2020)
5.3.6 Global Point-of-Care Infectious Disease Diagnostics or Testing Consumption and Growth Rate of Others (2015-2020)
ALSO READ: http://www.marketwatch.com/story/june-2021-report-o-n-global-boilin...
6 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Analysis by Regions
6.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Sales, Revenue and Market Share by Regions
6.1.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Sales by Regions (2015-2020)
6.1.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Revenue by Regions (2015-2020)
6.2 North America Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
6.3 Europe Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
6.6 South America Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
7 North America Point-of-Care Infectious Disease Diagnostics or Testing Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Point-of-Care Infectious Disease Diagnostics or Testing Sales, Revenue and Market Share by Countries
7.2.1 North America Point-of-Care Infectious Disease Diagnostics or Testing Sales by Countries (2015-2020)
7.2.2 North America Point-of-Care Infectious Disease Diagnostics or Testing Revenue by Countries (2015-2020)
7.3 United States Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
7.4 Canada Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
7.5 Mexico Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
8 Europe Point-of-Care Infectious Disease Diagnostics or Testing Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Point-of-Care Infectious Disease Diagnostics or Testing Sales, Revenue and Market Share by Countries
8.2.1 Europe Point-of-Care Infectious Disease Diagnostics or Testing Sales by Countries (2015-2020)
8.2.2 Europe Point-of-Care Infectious Disease Diagnostics or Testing Revenue by Countries (2015-2020)
8.3 Germany Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
8.4 UK Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
8.5 France Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
8.6 Italy Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
8.7 Spain Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
8.8 Russia Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
9 Asia Pacific Point-of-Care Infectious Disease Diagnostics or Testing Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Point-of-Care Infectious Disease Diagnostics or Testing Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Point-of-Care Infectious Disease Diagnostics or Testing Sales by Countries (2015-2020)
9.2.2 Asia Pacific Point-of-Care Infectious Disease Diagnostics or Testing Revenue by Countries (2015-2020)
9.3 China Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
9.4 Japan Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
9.5 South Korea Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
9.6 India Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
9.8 Australia Point-of-Care Infectious Disease Diagnostics or Testing Sales and Growth Rate (2015-2020)
…………..Continued
CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105